{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T20:03:55Z","timestamp":1767211435482,"version":"3.44.0"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Immunology"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.cellimm.2021.104476","type":"journal-article","created":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T11:19:18Z","timestamp":1641813558000},"page":"104476","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Role of Suppressor of cytokine signaling 2 during the development and resolution of an experimental arthritis"],"prefix":"10.1016","volume":"372","author":[{"given":"Allysson","family":"Cramer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9943-8349","authenticated-orcid":false,"given":"Izabela","family":"Galv\u00e3o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nath\u00e1lia","family":"Venturini de S\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulo","family":"Gaio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nat\u00e1lia","family":"Fernanda de Melo Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana","family":"Rates Gonzaga Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Henrique Campolina-Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Vinicius Santos Valiate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernanda","family":"Rezende Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geovanni","family":"Dantas Cassali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauro","family":"Martins Teixeira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fl\u00e1vio","family":"Almeida Amaral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabiana","family":"Sim\u00e3o Machado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.cellimm.2021.104476_b0005","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/nrd.2016.21","article-title":"Rheumatoid arthritis: Current and future trends","volume":"15","author":"Chaudhari","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"issue":"10055","key":"10.1016\/j.cellimm.2021.104476_b0010","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","article-title":"Rheumatoid arthritis","volume":"388","author":"Smolen","year":"2016","journal-title":"Lancet."},{"key":"10.1016\/j.cellimm.2021.104476_b0015","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.berh.2018.10.005","article-title":"van der Helm-van Mil, Update on the epidemiology, risk factors, and disease outcomes of rheumatoid arthritis","volume":"32","author":"van der Woude","year":"2018","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"10.1016\/j.cellimm.2021.104476_b0020","doi-asserted-by":"crossref","unstructured":"J.S. Smolen, R.B.M. Landew\u00e9, J.W.J. Bijlsma, G.R. Burmester, M. Dougados, A. Kerschbaumer, I.B. McInnes, A. Sepriano, R.F. Van Vollenhoven, M. De Wit, D. Aletaha, M. Aringer, J. Askling, A. Balsa, M. Boers, A.A. Den Broeder, M.H. Buch, F. Buttgereit, R. Caporali, M.H. Cardiel, D. De Cock, C. Codreanu, M. Cutolo, C.J. Edwards, Y. Van Eijk-Hustings, P. Emery, A. Finckh, L. Gossec, J.E. Gottenberg, M.L. Hetland, T.W.J. Huizinga, M. Koloumas, Z. Li, X. Mariette, U. M\u00fcller-Ladner, E.F. Mysler, J.A.P. Da Silva, G. Po\u00f3r, J.E. Pope, A. Rubbert-Roth, A. Ruyssen-Witrand, K.G. Saag, A. Strangfeld, T. Takeuchi, M. Voshaar, R. Westhovens, D. Van Der Heijde, EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update, Ann. Rheum. Dis. 79 (2020) S685\u2013S699. https:\/\/doi.org\/10.1136\/annrheumdis-2019-216655.","DOI":"10.1136\/annrheumdis-2019-216655"},{"key":"10.1016\/j.cellimm.2021.104476_b0025","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1001\/jama.2018.13103","article-title":"Diagnosis and Management of Rheumatoid Arthritis: A Review","volume":"320","author":"Aletaha","year":"2018","journal-title":"JAMA - J. Am. Med. Assoc."},{"issue":"2","key":"10.1016\/j.cellimm.2021.104476_b0030","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41584-018-0155-9","article-title":"Selective Janus kinase inhibitors come of age","volume":"15","author":"O\u2019Shea","year":"2019","journal-title":"Nat. Rev. Rheumatol."},{"issue":"2","key":"10.1016\/j.cellimm.2021.104476_b0035","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3109\/08977194.2012.660936","article-title":"Biology and significance of the JAK\/STAT signalling pathways","volume":"30","author":"Kiu","year":"2012","journal-title":"Growth Factors."},{"issue":"4","key":"10.1016\/j.cellimm.2021.104476_b0040","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.semcdb.2008.07.010","article-title":"SOCS regulation of the JAK\/STAT signalling pathway","volume":"19","author":"Croker","year":"2008","journal-title":"Semin. Cell Dev. Biol."},{"issue":"6","key":"10.1016\/j.cellimm.2021.104476_b0045","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/nri2093","article-title":"SOCS proteins, cytokine signalling and immune regulation","volume":"7","author":"Yoshimura","year":"2007","journal-title":"Nat. Rev. Immunol."},{"issue":"10","key":"10.1016\/j.cellimm.2021.104476_b0050","doi-asserted-by":"crossref","first-page":"13521","DOI":"10.1007\/s13277-016-5215-7","article-title":"The suppressor of cytokine signaling 2 (SOCS2) inhibits tumor metastasis in hepatocellular carcinoma","volume":"37","author":"Cui","year":"2016","journal-title":"Tumor Biol."},{"key":"10.1016\/j.cellimm.2021.104476_b0055","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1530\/ERC-13-0446","article-title":"SOCS2 correlates with malignancy and exerts growth-promoting effects in prostate cancer","volume":"21","author":"Hoefer","year":"2014","journal-title":"Endocr. Relat. Cancer."},{"issue":"4","key":"10.1016\/j.cellimm.2021.104476_b0060","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/bjc.2014.377","article-title":"Identification of SOCS2 and SOCS6 as biomarkers in human colorectal cancer","volume":"111","author":"Letellier","year":"2014","journal-title":"Br. J. Cancer."},{"key":"10.1016\/j.cellimm.2021.104476_b0065","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/1096-9861(20000724)423:2<348::AID-CNE11>3.0.CO;2-W","article-title":"Expression of \u201csuppressor of cytokine signalling\u201d (SOCS) genes in the developing and adult mouse nervous system","volume":"423","author":"Polizzotto","year":"2000","journal-title":"J. Comp. Neurol."},{"issue":"3","key":"10.1016\/j.cellimm.2021.104476_b0070","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.neuroscience.2004.12.041","article-title":"Analysis of neuronal subpopulations in mice over-expressing suppressor of cytokine signaling-2","volume":"132","author":"Ransome","year":"2005","journal-title":"Neuroscience."},{"key":"10.1016\/j.cellimm.2021.104476_b0075","first-page":"366","article-title":"Growth hormone and SOCS2 regulation of neuronal differentiation: Possible role in mental function","volume":"2","author":"Turnley","year":"2005","journal-title":"Pediatr. Endocrinol. Rev."},{"issue":"2","key":"10.1016\/j.cellimm.2021.104476_b0080","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.tem.2005.01.006","article-title":"Role of SOCS2 in growth hormone actions","volume":"16","author":"Turnley","year":"2005","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.cellimm.2021.104476_b0085","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.bbi.2016.01.002","article-title":"Suppressor of cytokine signaling 2 modulates the immune response profile and development of experimental cerebral malaria","volume":"54","author":"Brant","year":"2016","journal-title":"Brain. Behav. Immun."},{"key":"10.1016\/j.cellimm.2021.104476_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/1872593","article-title":"Role of SOCS2 in the Regulation of Immune Response and Development of the Experimental Autoimmune Encephalomyelitis","volume":"2019","author":"Cramer","year":"2019","journal-title":"Mediators Inflamm."},{"issue":"1","key":"10.1016\/j.cellimm.2021.104476_b0095","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ajpath.2012.03.042","article-title":"Role of SOCS2 in modulating heart damage and function in a murine model of acute Chagas disease","volume":"181","author":"Esper","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.cellimm.2021.104476_b0100","doi-asserted-by":"crossref","first-page":"108304","DOI":"10.1016\/j.jnutbio.2019.108304","article-title":"SOCS2 modulates adipose tissue inflammation and expansion in mice","volume":"76","author":"Val","year":"2020","journal-title":"J. Nutr. Biochem."},{"issue":"8","key":"10.1016\/j.cellimm.2021.104476_b0105","doi-asserted-by":"crossref","first-page":"3282","DOI":"10.1096\/fj.12-205583","article-title":"SOCS2 deletion protects against hepatic steatosis but worsens insulin resistance in high-fat-diet-fed mice","volume":"26","author":"Zadjali","year":"2012","journal-title":"FASEB J."},{"key":"10.1016\/j.cellimm.2021.104476_b0110","first-page":"72","article-title":"Cooperative role of tumour necrosis factor-a, interleukin-1b and neutrophils in a novel behavioural model that concomitantly demonstrates articular inflammation and hypernociception in mice CONCLUSIONS AND IMPLICATIONS","volume":"162","author":"Sachs","year":"2011","journal-title":"J. Pharmacol."},{"key":"10.1016\/j.cellimm.2021.104476_b0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/ar1039","article-title":"Susceptibility to collagen-induced arthritis is modulated by TGFbeta responsiveness of T cells","volume":"6","author":"Schramm","year":"2004","journal-title":"Arthritis Res. Ther."},{"issue":"1","key":"10.1016\/j.cellimm.2021.104476_b0120","doi-asserted-by":"crossref","DOI":"10.1186\/s12891-018-2391-1","article-title":"Time course analyses of structural changes in the infrapatellar fat pad and synovial membrane during inflammation-induced persistent pain development in rat knee joint","volume":"20","author":"Inomata","year":"2019","journal-title":"BMC Musculoskelet. Disord."},{"issue":"8","key":"10.1016\/j.cellimm.2021.104476_b0125","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1002\/art.23622","article-title":"The chemokine receptors CXCR1\/CXCR2 modulate antigen-induced arthritis by regulating adhesion of neutrophils to the synovial microvasculature","volume":"58","author":"Coelho","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cellimm.2021.104476_b0130","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.01596","article-title":"Angiotensin-(1\u20137) promotes resolution of neutrophilic inflammation in a model of antigen-induced arthritis in mice","volume":"8","author":"Barroso","year":"2017","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.cellimm.2021.104476_b0135","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1002\/JLB.3A1018-389R","article-title":"The immunoreceptor CD300a controls the intensity of inflammation and dysfunction in a model of Ag-induced arthritis in mice","volume":"106","author":"Valiate","year":"2019","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.cellimm.2021.104476_b0140","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.662308","article-title":"Biochanin A Regulates Key Steps of Inflammation Resolution in a Model of Antigen-Induced Arthritis via GPR30\/PKA-Dependent Mechanism","volume":"12","author":"Felix","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.cellimm.2021.104476_b0145","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/imr.12453","article-title":"Clearance of apoptotic neutrophils and resolution of inflammation","volume":"273","author":"Greenlee-Wacker","year":"2016","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.cellimm.2021.104476_b0150","doi-asserted-by":"crossref","first-page":"330","DOI":"10.3390\/cells2020330","article-title":"Targeting Neutrophil Apoptosis for Enhancing the Resolution of Inflammation","volume":"2","author":"El Kebir","year":"2013","journal-title":"Cells."},{"issue":"3","key":"10.1016\/j.cellimm.2021.104476_b0155","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nm1355","article-title":"Anti-inflammatory actions of lipoxin A4 and aspirin-triggered lipoxin are SOCS-2 dependent","volume":"12","author":"Machado","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.cellimm.2021.104476_b0160","article-title":"SOCS2 is critical for the balancing of immune response and oxidate stress protecting against acetaminophen-induced acute liver injury","volume":"10","author":"Monti-Rocha","year":"2019","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.cellimm.2021.104476_b0165","doi-asserted-by":"crossref","first-page":"4665","DOI":"10.4049\/jimmunol.1300581","article-title":"Identification of a Tissue-Specific, C\/EBP\u03b2-Dependent Pathway of Differentiation for Murine Peritoneal Macrophages","volume":"191","author":"Cain","year":"2013","journal-title":"J. Immunol."},{"issue":"16","key":"10.1016\/j.cellimm.2021.104476_b0170","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.2174\/0929867325666180209145243","article-title":"Novel Therapeutic Approaches in Rheumatoid Arthritis: Role of Janus Kinases Inhibitors","volume":"26","author":"Rivellese","year":"2019","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.cellimm.2021.104476_b0175","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.clim.2016.09.014","article-title":"Role of the JAK\/STAT signaling pathway in regulation of innate immunity in neuroinflammatory diseases","volume":"189","author":"Yan","year":"2018","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.cellimm.2021.104476_b0180","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2174\/157436209789057467","article-title":"Targeting JAK\/STAT Signaling Pathway in Inflammatory Diseases","volume":"4","author":"Malemud","year":"2009","journal-title":"Curr. Signal Transduct. Ther."},{"issue":"5","key":"10.1016\/j.cellimm.2021.104476_b0185","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s40265-017-0701-9","article-title":"JAK\u2013STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future Prospects","volume":"77","author":"Banerjee","year":"2017","journal-title":"Drugs."},{"key":"10.1016\/j.cellimm.2021.104476_b0190","doi-asserted-by":"crossref","first-page":"519","DOI":"10.2147\/JIR.S219586","article-title":"Jak inhibitors in rheumatoid arthritis: An evidence-based review on the emerging clinical data","volume":"13","author":"Harrington","year":"2020","journal-title":"J. Inflamm. Res."},{"issue":"4","key":"10.1016\/j.cellimm.2021.104476_b0195","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1080\/25785826.2020.1770948","article-title":"JAK inhibitors for the treatment of rheumatoid arthritis","volume":"43","author":"Morinobu","year":"2020","journal-title":"Immunol. Med."},{"key":"10.1016\/j.cellimm.2021.104476_b0200","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1093\/rheumatology\/kem198","article-title":"The expression of SOCS is altered in rheumatoid arthritis","volume":"46","author":"Isom\u00e4ki","year":"2007","journal-title":"Rheumatology."},{"key":"10.1016\/j.cellimm.2021.104476_b0205","first-page":"646.4-646","article-title":"AB0150 Regulation of SOCS1, SOCS2 and SOCS3 expression in patients with early arthritis","volume":"71","author":"Ortiz","year":"2013","journal-title":"Ann. Rheum. Dis."},{"issue":"4","key":"10.1016\/j.cellimm.2021.104476_b0210","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s10238-008-0006-0","article-title":"The analysis of CIS, SOCS1, SOSC2 and SOCS3 transcript levels in peripheral blood mononuclear cells of systemic lupus erythematosus and rheumatoid arthritis patients","volume":"8","author":"Tsao","year":"2008","journal-title":"Clin. Exp. Med."},{"issue":"11","key":"10.1016\/j.cellimm.2021.104476_b0215","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1002\/art.34649","article-title":"JAK inhibition with tofacitinib suppresses arthritic joint structural damage through decreased RANKL production","volume":"64","author":"LaBranche","year":"2012","journal-title":"Arthritis Rheum."},{"issue":"530","key":"10.1016\/j.cellimm.2021.104476_b0220","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay4447","article-title":"JAK inhibition increases bone mass in steady-state conditions and ameliorates pathological bone loss by stimulating osteoblast function","volume":"12","author":"Adam","year":"2020","journal-title":"Sci. Transl. Med."},{"issue":"16","key":"10.1016\/j.cellimm.2021.104476_b0225","doi-asserted-by":"crossref","first-page":"5754","DOI":"10.1523\/JNEUROSCI.5007-09.2010","article-title":"SOCS3-mediated blockade of JAK\/STAT3 signaling pathway reveals its major contribution to spinal cord neuroinflammation and mechanical allodynia after peripheral nerve injury","volume":"30","author":"Dominguez","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.cellimm.2021.104476_b0230","doi-asserted-by":"crossref","unstructured":"T.M. Cunha, J. Talbot, L.G. Pinto, S.M. Vieira, G.R. Souza, A.T. Guerrero, F. Sonego, W.A. Verri, D.S. Zamboni, S.H. Ferreira, F.Q. Cunha, Caspase-1 is involved in the genesis of inflammatory hypernociception by contributing to peripheral IL-1\u03b2 maturation, Mol. Pain. 6 (2010). https:\/\/doi.org\/10.1186\/1744-8069-6-63.","DOI":"10.1186\/1744-8069-6-63"},{"key":"10.1016\/j.cellimm.2021.104476_b0235","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1002\/eji.200323897","article-title":"Chemokines integrate JAK\/STAT and G-protein pathways during chemotaxis and calcium flux responses","volume":"33","author":"Soriano","year":"2003","journal-title":"Eur. J. Immunol."},{"issue":"5","key":"10.1016\/j.cellimm.2021.104476_b0240","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1189\/jlb.0306209","article-title":"Molecular mechanisms involved in interleukin-4-induced human neutrophils: expression and regulation of suppressor of cytokine signaling","volume":"81","author":"Ratth\u00e9","year":"2007","journal-title":"J. Leukoc. Biol."},{"issue":"7","key":"10.1016\/j.cellimm.2021.104476_b0245","doi-asserted-by":"crossref","first-page":"4234","DOI":"10.4049\/jimmunol.1003668","article-title":"Modulation of Innate and Adaptive Immune Responses by Tofacitinib (CP-690,550)","volume":"186","author":"Ghoreschi","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2021.104476_b0250","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.pain.2009.11.006","article-title":"IL-17 mediates articular hypernociception in antigen-induced arthritis in mice","volume":"148","author":"Pinto","year":"2010","journal-title":"Pain."},{"key":"10.1016\/j.cellimm.2021.104476_b0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-10509-5","article-title":"Interleukin-17A is involved in mechanical hyperalgesia but not in the severity of murine antigen-induced arthritis","volume":"7","author":"Ebbinghaus","year":"2017","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.cellimm.2021.104476_b0260","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.4049\/jimmunol.1201396","article-title":"Regulation of Foxp3 + Inducible Regulatory T Cell Stability by SOCS2","volume":"190","author":"Knosp","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.cellimm.2021.104476_b0265","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1084\/jem.20110428","article-title":"SOCS1 is essential for regulatory T cell functions by preventing loss of Foxp3 expression as well as IFN-\u03b3 and IL-17A production","volume":"208","author":"Takahashi","year":"2011","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.cellimm.2021.104476_b0270","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.autrev.2018.02.001","article-title":"TCR\u03b1\u03b2+CD3+CD4\u2212CD8\u2212 (double negative) T cells in autoimmunity","volume":"17","author":"Brandt","year":"2018","journal-title":"Autoimmun. Rev."},{"issue":"12","key":"10.1016\/j.cellimm.2021.104476_b0275","doi-asserted-by":"crossref","first-page":"8761","DOI":"10.4049\/jimmunol.181.12.8761","article-title":"Expanded Double Negative T Cells in Patients with Systemic Lupus Erythematosus Produce IL-17 and Infiltrate the Kidneys","volume":"181","author":"Crisp\u00edn","year":"2008","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.cellimm.2021.104476_b0280","doi-asserted-by":"crossref","first-page":"4289","DOI":"10.4049\/jimmunol.1103701","article-title":"CD4 + CD8 + T Cells Represent a Significant Portion of the Anti-HIV T Cell Response to Acute HIV Infection","volume":"188","author":"Frahm","year":"2012","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.cellimm.2021.104476_b0285","doi-asserted-by":"crossref","first-page":"5558","DOI":"10.1073\/pnas.1814394116","article-title":"Double-negative T cells remarkably promote neuroinflammation after ischemic stroke","volume":"116","author":"Meng","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"10.1016\/j.cellimm.2021.104476_b0290","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1002\/art.22927","article-title":"Presence of CD4+CD8+ double-positive T cells with very high interleukin-4 production potential in lesional skin of patients with systemic sclerosis","volume":"56","author":"Parel","year":"2007","journal-title":"Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.cellimm.2021.104476_b0295","doi-asserted-by":"crossref","first-page":"e93293","DOI":"10.1371\/journal.pone.0093293","article-title":"Peripheral CD4CD8 double positive t cells with a distinct helper cytokine profile are increased in rheumatoid arthritis","volume":"9","author":"Quandt","year":"2014","journal-title":"PLoS One."},{"key":"10.1016\/j.cellimm.2021.104476_b0300","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.phrs.2016.01.027","article-title":"Neutrophils and arthritis: Role in disease and pharmacological perspectives","volume":"112","author":"Fattori","year":"2016","journal-title":"Pharmacol. Res."},{"issue":"2","key":"10.1016\/j.cellimm.2021.104476_b0305","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.pharmthera.2013.04.006","article-title":"Resolution of inflammation: Mechanisms and opportunity for drug development","volume":"139","author":"Alessandri","year":"2013","journal-title":"Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.cellimm.2021.104476_b0310","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/2211-5463.12584","article-title":"Macrophages engulf apoptotic and primary necrotic thymocytes through similar phosphatidylserine-dependent mechanisms","volume":"9","author":"Budai","year":"2019","journal-title":"FEBS Open Bio."},{"issue":"10","key":"10.1016\/j.cellimm.2021.104476_b0315","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1128\/IAI.00575-16","article-title":"The aryl hydrocarbon receptor modulates production of cytokines and reactive oxygen species and development of myocarditis during Trypanosoma cruzi infection","volume":"84","author":"Barroso","year":"2016","journal-title":"Infect. Immun."},{"key":"10.1016\/j.cellimm.2021.104476_b0320","doi-asserted-by":"crossref","first-page":"104427","DOI":"10.1016\/j.cellimm.2021.104427","article-title":"Role of formyl peptide receptor 2 (FPR2) in modulating immune response and heart inflammation in an experimental model of acute and chronic Chagas disease","volume":"369","author":"das Dores Pereira","year":"2021","journal-title":"Cell. Immunol."},{"issue":"4","key":"10.1016\/j.cellimm.2021.104476_b0325","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.4049\/jimmunol.164.4.1663","article-title":"Cutting Edge: Lipoxins Rapidly Stimulate Nonphlogistic Phagocytosis of Apoptotic Neutrophils by Monocyte-Derived Macrophages","volume":"164","author":"Godson","year":"2000","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.cellimm.2021.104476_b0330","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/cdd.2009.220","article-title":"Lipoxin A4 impairment of apoptotic signaling in macrophages: Implication of the PI3K\/Akt and the ERK\/Nrf-2 defense pathways","volume":"17","author":"Prieto","year":"2010","journal-title":"Cell Death Differ."},{"issue":"10","key":"10.1016\/j.cellimm.2021.104476_b0335","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1097\/01.ASN.0000032417.73640.72","article-title":"Lipoxins, aspirin-triggered epi-lipoxins, lipoxin stable analogues, and the resolution of inflammation: Stimulation of macrophage phagocytosis of apoptotic neutrophils in vivo","volume":"13","author":"Mitchell","year":"2002","journal-title":"J. Am. Soc. Nephrol."}],"container-title":["Cellular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874921001970?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874921001970?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T23:07:01Z","timestamp":1757804821000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008874921001970"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":67,"alternative-id":["S0008874921001970"],"URL":"https:\/\/doi.org\/10.1016\/j.cellimm.2021.104476","relation":{},"ISSN":["0008-8749"],"issn-type":[{"type":"print","value":"0008-8749"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of Suppressor of cytokine signaling 2 during the development and resolution of an experimental arthritis","name":"articletitle","label":"Article Title"},{"value":"Cellular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellimm.2021.104476","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104476"}}